IC
NUVB icon

IEQ Capital’s Nuvation Bio NUVB Stock Holding History

IEQ Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Buy
235,185
+1,833
+0.8% +$8.96K 0.01% 986
2026
Q1 		$1M Sell
233,352
-40,709
-15% -$227K ﹤0.01% 1047
2025
Q4 		$2.46M Sell
274,061
-24,306
-8% -$151K 0.01% 724
2025
Q3 		$1.1M Buy
298,367
+181,185
+155% +$494K ﹤0.01% 972
2025
Q2 		$229K Buy
117,182
+89,767
+327% +$187K ﹤0.01% 1544
2025
Q1 		$48.3K Sell
27,415
-9,578
-26% -$21.8K ﹤0.01% 1550
2024
Q4 		$98.4K Buy
+36,993
New +$95.2K ﹤0.01% 1268

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

IEQ Capital's NUVB Position: Q2 2026 in Review

IEQ Capital increased its Nuvation Bio (NUVB) stake by 0.79% in Q2 2026, buying an estimated $8.96K and bringing the position to 235,185 shares worth $1.34M. The position accounts for 0.01% of the portfolio, ranked #986.

IEQ Capital first reported a position in NUVB in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.46M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • IEQ Capital held 235,185 shares of Nuvation Bio worth $1.34M as of Q2 2026.
  • IEQ Capital bought 1,833 Nuvation Bio shares in Q2 2026, an estimated $8.96K.
  • Nuvation Bio made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #986 holding.
  • IEQ Capital first reported a position in Nuvation Bio in Q4 2024 and has held it in 7 quarters since.
  • IEQ Capital's Nuvation Bio position peaked at $2.46M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.